Analysis of risk factors in patients with severe chronic kidney disease. The role of atorvastatin.
Background and aim: There had been no randomized end-point studies with statins for patients with severe renal failure. The purpose of this prospective, open, randomized, controlled study was to investigate whether atorvastatin (10 mg/day) would alter cardiovascular end-points and the overall mortal...
Main Author: | Holmberg, Benny |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Umeå universitet, Medicin
2013
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-68682 http://nbn-resolving.de/urn:isbn:978-91-7459-554-3 |
Similar Items
-
Testosterone deficiency in dialysis patients: Differences according to the dialysis techniques
by: Secundino Cigarrán, et al.
Published: (2017-09-01) -
End-stage kidney disease in patient with epidermolysis bullosa - what are the treatment options? – case report
by: Michał Małecki, et al.
Published: (2017-06-01) -
Serum levels of the adipomyokine irisin in patients with chronic kidney disease
by: Ana Rodríguez-Carmona, et al.
Published: (2016-09-01) -
Peritoneal Dialysis or Haemodialysis for Kidney Failure?
by: Badri Man Shrestha
Published: (2018-04-01) -
Periodontal inflamed surface area in patients on haemodialysis and peritoneal dialysis: a Croatian cross-sectional study
by: Bojana Križan Smojver, et al.
Published: (2020-04-01)